Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target. 2013

Hideo Watanabe, and Joshua M Francis, and Michele S Woo, and Banafsheh Etemad, and Wenchu Lin, and Daniel F Fries, and Shouyong Peng, and Eric L Snyder, and Purushothama Rao Tata, and Francesca Izzo, and Anna C Schinzel, and Jeonghee Cho, and Peter S Hammerman, and Roel G Verhaak, and William C Hahn, and Jayaraj Rajagopal, and Tyler Jacks, and Matthew Meyerson
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.

The NKX2-1 transcription factor, a regulator of normal lung development, is the most significantly amplified gene in human lung adenocarcinoma. To study the transcriptional impact of NKX2-1 amplification, we generated an expression signature associated with NKX2-1 amplification in human lung adenocarcinoma and analyzed DNA-binding sites of NKX2-1 by genome-wide chromatin immunoprecipitation. Integration of these expression and cistromic analyses identified LMO3, itself encoding a transcription regulator, as a candidate direct transcriptional target of NKX2-1. Further cistromic and overexpression analyses indicated that NKX2-1 can cooperate with the forkhead box transcription factor FOXA1 to regulate LMO3 gene expression. RNAi analysis of NKX2-1-amplified cells compared with nonamplified cells demonstrated that LMO3 mediates cell survival downstream from NKX2-1. Our findings provide new insight into the transcriptional regulatory network of NKX2-1 and suggest that LMO3 is a transcriptional signal transducer in NKX2-1-amplified lung adenocarcinomas.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002843 Chromatin The material of CHROMOSOMES. It is a complex of DNA; HISTONES; and nonhistone proteins (CHROMOSOMAL PROTEINS, NON-HISTONE) found within the nucleus of a cell. Chromatins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074482 Thyroid Nuclear Factor 1 A homeobox protein and transcription factor that localizes to the cell nucleus where it activates expression of thyroid specific genes such as THYROGLOBULIN and the THYROTROPIN RECEPTOR. It is critical for maintaining thyroid tissue in a differentiated state and also plays a role in lung development. Mutations in the NKX2-1 gene are associated with CHOREA, BENIGN HEREDITARY. Homeobox Protein Nkx-2.1,NK2 Homeobox 1 Protein,TITF-1 Protein,TITF1 Protein,TTF-1 Thyroid Nuclear Factor,Thyroid Transcription Factor 1,Thyroid-Specific Enhancer-Binding Protein,Enhancer-Binding Protein, Thyroid-Specific,Homeobox Protein Nkx 2.1,Nkx-2.1, Homeobox Protein,TITF 1 Protein,TTF 1 Thyroid Nuclear Factor,Thyroid Specific Enhancer Binding Protein
D000077192 Adenocarcinoma of Lung A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer. Lung Adenocarcinoma,Adenocarcinoma, Lung,Adenocarcinomas, Lung,Lung Adenocarcinomas
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic

Related Publications

Hideo Watanabe, and Joshua M Francis, and Michele S Woo, and Banafsheh Etemad, and Wenchu Lin, and Daniel F Fries, and Shouyong Peng, and Eric L Snyder, and Purushothama Rao Tata, and Francesca Izzo, and Anna C Schinzel, and Jeonghee Cho, and Peter S Hammerman, and Roel G Verhaak, and William C Hahn, and Jayaraj Rajagopal, and Tyler Jacks, and Matthew Meyerson
November 2018, Molecular cancer research : MCR,
Hideo Watanabe, and Joshua M Francis, and Michele S Woo, and Banafsheh Etemad, and Wenchu Lin, and Daniel F Fries, and Shouyong Peng, and Eric L Snyder, and Purushothama Rao Tata, and Francesca Izzo, and Anna C Schinzel, and Jeonghee Cho, and Peter S Hammerman, and Roel G Verhaak, and William C Hahn, and Jayaraj Rajagopal, and Tyler Jacks, and Matthew Meyerson
March 2010, Oncogene,
Hideo Watanabe, and Joshua M Francis, and Michele S Woo, and Banafsheh Etemad, and Wenchu Lin, and Daniel F Fries, and Shouyong Peng, and Eric L Snyder, and Purushothama Rao Tata, and Francesca Izzo, and Anna C Schinzel, and Jeonghee Cho, and Peter S Hammerman, and Roel G Verhaak, and William C Hahn, and Jayaraj Rajagopal, and Tyler Jacks, and Matthew Meyerson
January 2024, iScience,
Hideo Watanabe, and Joshua M Francis, and Michele S Woo, and Banafsheh Etemad, and Wenchu Lin, and Daniel F Fries, and Shouyong Peng, and Eric L Snyder, and Purushothama Rao Tata, and Francesca Izzo, and Anna C Schinzel, and Jeonghee Cho, and Peter S Hammerman, and Roel G Verhaak, and William C Hahn, and Jayaraj Rajagopal, and Tyler Jacks, and Matthew Meyerson
January 2017, Cancer research,
Hideo Watanabe, and Joshua M Francis, and Michele S Woo, and Banafsheh Etemad, and Wenchu Lin, and Daniel F Fries, and Shouyong Peng, and Eric L Snyder, and Purushothama Rao Tata, and Francesca Izzo, and Anna C Schinzel, and Jeonghee Cho, and Peter S Hammerman, and Roel G Verhaak, and William C Hahn, and Jayaraj Rajagopal, and Tyler Jacks, and Matthew Meyerson
May 2011, Nature,
Hideo Watanabe, and Joshua M Francis, and Michele S Woo, and Banafsheh Etemad, and Wenchu Lin, and Daniel F Fries, and Shouyong Peng, and Eric L Snyder, and Purushothama Rao Tata, and Francesca Izzo, and Anna C Schinzel, and Jeonghee Cho, and Peter S Hammerman, and Roel G Verhaak, and William C Hahn, and Jayaraj Rajagopal, and Tyler Jacks, and Matthew Meyerson
January 2019, Technology in cancer research & treatment,
Hideo Watanabe, and Joshua M Francis, and Michele S Woo, and Banafsheh Etemad, and Wenchu Lin, and Daniel F Fries, and Shouyong Peng, and Eric L Snyder, and Purushothama Rao Tata, and Francesca Izzo, and Anna C Schinzel, and Jeonghee Cho, and Peter S Hammerman, and Roel G Verhaak, and William C Hahn, and Jayaraj Rajagopal, and Tyler Jacks, and Matthew Meyerson
March 2023, Cell reports,
Hideo Watanabe, and Joshua M Francis, and Michele S Woo, and Banafsheh Etemad, and Wenchu Lin, and Daniel F Fries, and Shouyong Peng, and Eric L Snyder, and Purushothama Rao Tata, and Francesca Izzo, and Anna C Schinzel, and Jeonghee Cho, and Peter S Hammerman, and Roel G Verhaak, and William C Hahn, and Jayaraj Rajagopal, and Tyler Jacks, and Matthew Meyerson
May 2014, Cancer research,
Hideo Watanabe, and Joshua M Francis, and Michele S Woo, and Banafsheh Etemad, and Wenchu Lin, and Daniel F Fries, and Shouyong Peng, and Eric L Snyder, and Purushothama Rao Tata, and Francesca Izzo, and Anna C Schinzel, and Jeonghee Cho, and Peter S Hammerman, and Roel G Verhaak, and William C Hahn, and Jayaraj Rajagopal, and Tyler Jacks, and Matthew Meyerson
April 2013, Molecular cell,
Hideo Watanabe, and Joshua M Francis, and Michele S Woo, and Banafsheh Etemad, and Wenchu Lin, and Daniel F Fries, and Shouyong Peng, and Eric L Snyder, and Purushothama Rao Tata, and Francesca Izzo, and Anna C Schinzel, and Jeonghee Cho, and Peter S Hammerman, and Roel G Verhaak, and William C Hahn, and Jayaraj Rajagopal, and Tyler Jacks, and Matthew Meyerson
May 2021, Communications biology,
Copied contents to your clipboard!